Temporal trends in the treatment of over 1.5 million patients with myocardial infarction in the U.S. from 1990 through 1999: The National Registry of Myocardial Infarction 1, 2 and 3

Journal of the American College of Cardiology

Volumn 36, Issue 7, 2000, Pages 2056-2063

  Rogers, William J ^a   Canto, John G ^a   Lambrew, Costas T ^b   Tiefenbrunn, Alan J ^c   Kinkaid, Becky ^d   Shoultz, David A ^e   Frederick, Paul D ^e   Every, Nathan ^e  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b MAINE MEDICAL CENTER   (United States)

^c WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d GENENTECH INC   (United States)

^e UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

ADULT; AGED; ARTICLE; CORONARY ARTERY BYPASS GRAFT; FEMALE; FIBRINOLYTIC THERAPY; HEART INFARCTION; HEART MUSCLE REPERFUSION; HUMAN; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRACTICE GUIDELINE; PRIORITY JOURNAL; Q WAVE; REGISTER; TIME; TRANSLUMINAL CORONARY ANGIOPLASTY; UNITED STATES;

ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CORONARY ARTERY BYPASS; HUMANS; LENGTH OF STAY; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION; PHYSICIAN'S PRACTICE PATTERNS; REGISTRIES; THROMBOLYTIC THERAPY; TREATMENT OUTCOME; UNITED STATES;

EID: 0033662123     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(00)00996-7     Document Type: Article

References (23)

1. Routine medical management of acute myocardial infarction: Lessons from overviews of recent randomized controlled trials
2. ACC/AHA guidelines for the management of patients with acute myocardial infarction: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction)
3. Treatment of myocardial infarction in the United States (1990 to 1993): Observations from the National Registry of Myocardial Infarction
4. Emergency department: Rapid identification and treatment of patients with acute myocardial infarction
5. Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction
6. Effects of tissue plasminogen activator and a comparison of early invasive and conservative strategies in unstable angina and non-Q-wave myocardial infarction: Results of the TIMI IIIB trial
7. Use of reperfusion therapy for acute myocardial infarction in the United States: Data from the National Registry of Myocardial Infarction 2
8. Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2
9. Consultation before thrombolytic therapy in acute myocardial infarction
10. Aspirin as a therapeutic agent in cardiovascular disease
11. Beta blockade during and after myocardial infarction: An overview of the randomized trials
12. Indications for ACE inhibitors in the early treatment of acute myocardial infarction
13. Nifedipine: Dose-related increase in mortality in patients with coronary heart disease
14. Effects of prophylactic lidocaine in suspected acute myocardial infarction: An overview of results from the randomized, controlled trials
15. Single-bolus tenecteplase compared with front-loaded alteplase in acute myocardial infarction: The ASSENT-2 double-blind randomised trial
16. Comparison of invasive and conservative strategies after treatment with intravenous tissue plasminogen activator in acute myocardial infarction: Results of the Thrombolysis in Myocardial Infarction (TIMI) phase II trial
17. SWIFT trial of delayed elective intervention vs. conservative treatment after thrombolysis with anistreplase in acute myocardial infarction
18. Outcomes in patients with acute non-Q-wave myocardial infarction randomly assigned to an invasive as compared with a conservative management strategy
19. Invasive compared with non-invasive treatment in unstable coronary-artery disease: FRISC II prospective randomised multicentre study
20. Critical pathways as a strategy for improving care: Problems and potential
21. Implications of recurrent ischemia after reperfusion therapy in acute myocardial infarction: A comparison of thrombolytic therapy and primary angioplasty
22. Outcome of patients with acute myocardial infarction who are ineligible for thrombolytic therapy
23. A comparison of the National Registry of Myocardial Infarction 2 with the cooperative cardiovascular project